Molecular mechanisms of HIV-1 proviral latency

References

• Zhang Z, Schuler T, Zupancic M et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286(5443), 1353–1357 (1999).
   PubMed Web of Science ®Google Scholar
• Tisdale M, Kemp SD, Parry NR, Larder BA. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3´-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc. Natl Acad. Sci. USA 90(12), 5653–5656 (1993).
   PubMed Web of Science ®Google Scholar
• Palella FJ Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N. Engl. J. Med. 338(13), 853–860 (1998).
   PubMed Web of Science ®Google Scholar
• Gulick RM, Meibohm A, Havlir D et al. Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine. AIDS 17(16), 2345–2349 (2003).
   PubMed Web of Science ®Google Scholar
• Ho DD, Neumann AU, Perelson AS et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373(6510), 123–126 (1995).
   PubMed Web of Science ®Google Scholar
• Wei X, Ghosh SK, Taylor ME et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373(6510), 117–122 (1995).
   PubMed Web of Science ®Google Scholar
• Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271(5255), 1582–1586 (1996).
   PubMed Web of Science ®Google Scholar
• Perelson AS, Essunger P, Cao Y et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387(6629), 188–191 (1997).
   PubMed Web of Science ®Google Scholar
• Cohen OJ, Fauci AS. Current strategies in the treatment of HIV infection. Adv. Intern. Med. 46, 207–246 (2001).
   PubMedGoogle Scholar
• Davey RT Jr, Bhat N, Yoder C et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl Acad. Sci. USA 96(26), 15109–15114 (1999).
   PubMed Web of Science ®Google Scholar
• Chun TW, Finzi D, Margolick J et al. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nature Med. 1(12), 1284–1290 (1995).
   PubMed Web of Science ®Google Scholar
• Chun TW, Stuyver L, Mizell SB et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl Acad. Sci. USA 94(24), 13193–13197 (1997).
   PubMed Web of Science ®Google Scholar
• Siliciano JD, Kajdas J, Finzi D et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nature Med. 9(6), 727–728 (2003).
   PubMed Web of Science ®Google Scholar
• Pereira LA, Bentley K, Peeters A, Churchill MJ, Deacon NJ. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 28(3), 663–668 (2000).
   PubMed Web of Science ®Google Scholar
• Sheridan PL, Sheline CT, Cannon K et al. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev. 9(17), 2090–2104 (1995).
   PubMed Web of Science ®Google Scholar
• Rohr O, Marban C, Aunis D, Schaeffer E. Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells. J. Leukoc. Biol. 74(5), 736–749 (2003).
   PubMed Web of Science ®Google Scholar
• Van Lint C, Amella CA, Emiliani S et al. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J. Virol. 71(8), 6113–6127 (1997).
   PubMed Web of Science ®Google Scholar
• Chen LF, Greene WC. Shaping the nuclear action of NF-κB. Nat. Rev. Mol. Cell. Biol. 5(5), 392–401 (2004).
   PubMed Web of Science ®Google Scholar
• Ping YH, Rana TM. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J. Biol. Chem. 276(16), 12951–12958 (2001).
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Takagi T, Wada T et al. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97(1), 41–51 (1999).
   PubMed Web of Science ®Google Scholar
• Alonso A, Derse D, Peterlin BM. Human chromosome 12 is required for optimal interactions between Tat and TAR of human immunodeficiency virus type 1 in rodent cells. J. Virol. 66(7), 4617–4621 (1992).
   PubMed Web of Science ®Google Scholar
• Hart CE, Ou CY, Galphin JC et al. Human chromosome 12 is required for elevated HIV-1 expression in human–hamster hybrid cells. Science 246(4929), 488–491 (1989).
   PubMed Web of Science ®Google Scholar
• Herrmann CH, Rice AP. Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol. 69(3), 1612–1620 (1995).
   PubMed Web of Science ®Google Scholar
• Wei P, Garber ME, Fang SM, Fischer WH, Jones KA. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92(4), 451–462 (1998).
   PubMed Web of Science ®Google Scholar
• Fujinaga K, Irwin D, Huang Y et al. Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element. Mol. Cell. Biol. 24(2), 787–795 (2004).
   PubMed Web of Science ®Google Scholar
• Bourgeois CF, Kim YK, Churcher MJ, West MJ, Karn J. Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences. Mol. Cell. Biol. 22(4), 1079–1093 (2002).
   PubMed Web of Science ®Google Scholar
• Ivanov D, Kwak YT, Guo J, Gaynor RB. Domains in the SPT5 protein that modulate its transcriptional regulatory properties. Mol. Cell. Biol. 20(9), 2970–2983 (2000).
   PubMed Web of Science ®Google Scholar
• Fong YW, Zhou Q. Relief of two built-in autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter. Mol. Cell. Biol. 20(16), 5897–5907 (2000).
   PubMed Web of Science ®Google Scholar
• Garber ME, Mayall TP, Suess EM et al. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA. Mol. Cell. Biol. 20(18), 6958–6969 (2000).
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhu Q, Luo K, Zhou Q. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 414(6861), 317–322 (2001).
   PubMed Web of Science ®Google Scholar
• Nguyen VT, Kiss T, Michels AA, Bensaude O. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 414(6861), 322–325 (2001).
   PubMed Web of Science ®Google Scholar
• Ghose R, Liou LY, Herrmann CH, Rice AP. Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines. J. Virol. 75(23), 11336–11343 (2001).
   PubMed Web of Science ®Google Scholar
• Finch JT, Noll M, Kornberg RD. Electron microscopy of defined lengths of chromatin. Proc. Natl Acad. Sci. USA 72(9), 3320–3322 (1975).
   PubMed Web of Science ®Google Scholar
• Kornberg RD. Chromatin structure: a repeating unit of histones and DNA. Science 184(139), 868–871 (1974).
   PubMed Web of Science ®Google Scholar
• Thomas JO, Kornberg RD. An octamer of histones in chromatin and free in solution. Proc. Natl Acad. Sci. USA 72(7), 2626–2630 (1975).
   PubMed Web of Science ®Google Scholar
• Strahl BD, Allis CD. The language of covalent histone modifications. Nature 403(6765), 41–45 (2000).
   PubMed Web of Science ®Google Scholar
• Owen-Hughes T, Workman JL. Experimental analysis of chromatin function in transcription control. Crit. Rev. Eukaryot. Gene Expr. 4(4), 403–441 (1994).
   PubMedGoogle Scholar
• Knezetic JA, Luse DS. The presence of nucleosomes on a DNA template prevents initiation by RNA polymerase II in vitro. Cell 45(1), 95–104 (1986).
   PubMed Web of Science ®Google Scholar
• Steger DJ, Eberharter A, John S, Grant PA, Workman JL. Purified histone acetyltransferase complexes stimulate HIV-1 transcription from preassembled nucleosomal arrays. Proc. Natl Acad. Sci. USA 95(22), 12924–12929 (1998).
   PubMed Web of Science ®Google Scholar
• Verdin E, Paras P Jr, Van Lint C. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. Embo. J. 12(8), 3249–3259 (1993).
   PubMed Web of Science ®Google Scholar
• Steger DJ, Workman JL. Stable co-occupancy of transcription factors and histones at the HIV-1 enhancer. Embo. J. 16(9), 2463–2472 (1997).
   PubMed Web of Science ®Google Scholar
• Demarchi F, D'Agaro P, Falaschi A, Giacca M. In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 67(12), 7450–7460 (1993).
   PubMed Web of Science ®Google Scholar
• Lusic M, Marcello A, Cereseto A, Giacca M. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. Embo. J. 22(24), 6550–6561 (2003).
   PubMed Web of Science ®Google Scholar
• Henderson A, Holloway A, Reeves R, Tremethick DJ. Recruitment of SWI/SNF to the human immunodeficiency virus type 1 promoter. Mol. Cell. Biol. 24(1), 389–397 (2004).
   PubMed Web of Science ®Google Scholar
• Kiernan RE, Vanhulle C, Schiltz L et al. HIV-1 tat transcriptional activity is regulated by acetylation. Embo. J. 18(21), 6106–6118 (1999).
   PubMed Web of Science ®Google Scholar
• Ott M, Schnolzer M, Garnica J et al. Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr. Biol. 9(24), 1489–1492 (1999).
   PubMed Web of Science ®Google Scholar
• Kaehlcke K, Dorr A, Hetzer-Egger C et al. Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol. Cell. 12(1), 167–176 (2003).
   PubMed Web of Science ®Google Scholar
• Pagans S, Pedal A, North BJ et al. SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol. 3(2), E41 (2005).
   PubMedGoogle Scholar
• Pomerantz RJ, Trono D, Feinberg MB, Baltimore D. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61(7), 1271–1276 (1990).
   PubMed Web of Science ®Google Scholar
• Emiliani S, Van Lint C, Fischle F et al. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc. Natl Acad. Sci. USA 93(13), 6377–6381 (1996).
   PubMed Web of Science ®Google Scholar
• Emiliani S, Fischle W, Ott M et al. Mutations in the tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line. J. Virol. 72(2), 1666–1670 (1998).
   PubMed Web of Science ®Google Scholar
• Setterfield G, Hall R, Bladon T, Little J, Kaplan JG. Changes in structure and composition of lymphocyte nuclei during mitogenic stimulation. J. Ultrastruct. Res. 82(3), 264–282 (1983).
   PubMedGoogle Scholar
• Brown KE, Baxter J, Graf D, Merkenschlager M, Fisher AG. Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division. Mol. Cell. 3(2), 207–217 (1999).
   PubMed Web of Science ®Google Scholar
• Jordan A, Defechereux P, Verdin E. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. Embo. J. 20(7), 1726–1738 (2001).
   PubMed Web of Science ®Google Scholar
• Jordan A, Bisgrove D, Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. Embo. J. 22(8), 1868–1877 (2003).
   PubMed Web of Science ®Google Scholar
• Craig JM. Heterochromatin – many flavours, common themes. Bioessays 27(1), 17–28 (2005).
   PubMed Web of Science ®Google Scholar
• Han Y, Lassen K, Monie D et al. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J. Virol. 78(12), 6122–6133 (2004).
   PubMed Web of Science ®Google Scholar
• Chun TW, Carruth L, Finzi D et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387(6629), 183–188 (1997).
   PubMed Web of Science ®Google Scholar
• Lewinski MK, Bisgrove D, Shinn P et al. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J. Virol. 79(11), 6610–6619 (2005).
   PubMed Web of Science ®Google Scholar
• Schroder AR, Shinn P, Chen H et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110(4), 521–529 (2002).
   PubMed Web of Science ®Google Scholar
• Wu X, Li Y, Crise B, Burgess SM Transcription start regions in the human genome are favored targets for MLV integration. Science 300(5626), 1749–1751 (2003).
   PubMed Web of Science ®Google Scholar
• Greger IH, Demarchi F, Giacca M, Proudfoot NJ. Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter. Nucleic Acids Res. 26(5), 1294–1301 (1998).
   PubMed Web of Science ®Google Scholar
• Schramke V, Allshire R. Hairpin RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing. Science 301(5636), 1069–1074 (2003).
   PubMed Web of Science ®Google Scholar
• Ramratnam B, Mittler JE, Zhang L et al. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nature Med. 6(1), 82–85 (2000).
   PubMed Web of Science ®Google Scholar
• Dornadula G, Zhang H, VanUitert B et al. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. J. Am. Med. Assoc. 282(17), 1627–1632 (1999).
   PubMed Web of Science ®Google Scholar
• Ramratnam B, Ribeiro R, He T et al. Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication. J. Acquir. Immune Defic. Syndr. 35(1), 33–37 (2004).
   PubMed Web of Science ®Google Scholar
• Blankson JN, Persaud D, Siliciano RF. The challenge of viral reservoirs in HIV-1 infection. Ann. Rev. Med. 53, 557–593 (2002).
   PubMed Web of Science ®Google Scholar
• Smithgall MD, Wong JG, Critchett KE, Haffar OK. IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. J. Immunol. 156(6), 2324–2330 (1996).
   PubMed Web of Science ®Google Scholar
• Scripture-Adams DD, Brooks DG, Korin YD, Zack JA. Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J. Virol. 76(24), 13077–13082 (2002).
   PubMed Web of Science ®Google Scholar
• Gustafson KR, Cardellina JH II, McMahon JB et al. A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1. J. Med. Chem. 35(11), 1978–1986 (1992).
   PubMed Web of Science ®Google Scholar
• Korin YD, Brooks DG, Brown S, Korotzer A, Zack JA. Effects of prostratin on T-cell activation and human immunodeficiency virus latency. J. Virol. 76(16), 8118–8123 (2002).
   PubMed Web of Science ®Google Scholar
• Kulkosky J, Culnan DM, Roman J et al. Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood 98(10), 3006–3015 (2001).
   PubMed Web of Science ®Google Scholar
• Quivy V, Adam E, Collette Y et al. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-κB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. J. Virol. 76(21), 11091–11103 (2002).
   PubMed Web of Science ®Google Scholar
• Van Lint C, Emiliani S, Ott M, Verdin E. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. Embo. J. 15(5), 1112–1120 (1996).
   PubMed Web of Science ®Google Scholar
• Ylisastigui L, Archin NM, Lehrman G, Bosch RJ, Margolis DM. Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression. AIDS 18(8), 1101–1108 (2004).
   PubMed Web of Science ®Google Scholar